0001213900-26-025940
SEC filingMainz Biomed B.V. filed an 8-K on March 11, 2026, disclosing matters under Items 5.02, 7.01, and 8.01, including a departure or election of directors or officers, a furnished press release (Exhibit 99.1), and that ordinary shares will cease trading effective before market open on March 12, 2026.